Mechanisms of stimulation of the immune response by aluminum adjuvants.
about
T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injectionKinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvantRecombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes caseSynthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaquesAluminum-induced entropy in biological systems: implications for neurological diseaseIn Vivo Analysis of the Potency of Silicone Oil Microdroplets as Immunological Adjuvants in Protein FormulationsPoly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccineComplement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccineEffective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2.Antiallergic effect of an aqueous leaf extract of Pistia stratiotes in murine model of ovalbumin-induced allergic conjunctivitis.Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway.Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in miceSurvey of human-use adjuvants.Adjuvant properties of a biocompatible thermo-responsive polymer of N-isopropylacrylamide in autoimmunity and arthritis.A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challengeDeveloping a vaccine against multiple psychoactive targets: a case study of heroin.The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.Comparative evaluation of two hemagglutinating encephalomyelitis coronavirus vaccine candidates in mice.Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice.Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityDo vaccines modify the prevalence of asthma and allergies?Vaccine delivery using nanoparticles.Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.Improving vaccines by incorporating immunological coadjuvants.Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis.Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine.Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.Biology of immune responses to vaccines in elderly persons.A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant.Promising particle-based vaccines in cancer therapy.The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profileVaccination against foot-and-mouth disease virus: strategies and effectiveness.
P2860
Q24645758-5EC7355F-3782-4E23-972A-CCBF96643041Q24802323-B89F33C4-FA5D-4CA8-8F34-84850B7E0A45Q27028100-E42801D5-BE88-4A1D-9E42-9B8C7BFD1B77Q27317212-90392B5A-353D-488E-A7E7-B26F29B6988FQ28396107-41CC7CDA-B9F3-4D97-BA64-2F78646D87A5Q30376902-62FEC29C-BD25-4B49-9AF9-D2887C7DDBF9Q30400146-9F3DD37C-27A2-4034-ADE6-84E928BEBA13Q33302902-44AD5115-3493-478B-8CC6-B6D7B15C75C3Q33359620-71102C97-7E73-4DBF-AE0B-E93C16789240Q33994533-DEC3D284-4082-4C40-A3AD-CF5A363C60E9Q34201383-B0164BE7-E7C9-4FB1-8814-E39131F34C98Q34293599-210696A6-938D-406E-8742-B51727FFB68EQ34430020-76471491-E7A5-4B73-AB06-C42F54354657Q34484641-196AC123-192C-4E69-8EC9-1108DB08B7B5Q34990010-EDECA624-5CD0-4D45-AAAF-C694BABEA6FCQ35091726-3DC54C8C-28EC-4A14-BFDF-A2FA949AD176Q35192171-D7B5D11D-1B2A-4A90-A9A6-5C2857B902BCQ35467090-73382D96-CAE5-4AF7-B079-590F9FBA0659Q35531454-B3C11248-FD75-40D1-91D0-5891D0D749FCQ35892296-F7797376-4AA0-4EC9-9152-B25F5EFE8B71Q35998757-873644BA-58EE-4992-B933-E42B2FF20ADBQ36086269-B4B6A29C-1E0F-4197-BC1E-A86EA0256B92Q36452345-C9C73D8A-05BE-4E6C-A6F7-96CA6FE3383EQ36538834-6E9861AC-5DD6-44F2-9870-C1BB612C0AEEQ36689010-CB870428-5ABB-4B95-865F-A7501C6F25A7Q36712817-41AA43F1-CD4C-4DE5-A13F-9AF464C136C6Q36780136-2FC97A52-4C1C-4D0F-B738-35803F6F52F6Q36899084-C246C936-AA05-4185-A5FD-9EB954357D63Q36931389-32F1D19E-B507-4610-A444-7AB762BFEBF8Q36968256-0C825B84-6F75-40FA-8B31-E7052424B282Q36968308-DEA38B9B-CC13-41C1-9C67-8B7FE482A791Q36994089-C94A08B2-384C-4E53-B001-B211E128A603Q37034318-AD2589E0-DF7F-4F91-A765-3C4BAFFFBDD4Q37036694-6E0840AB-FA4B-444A-B1E0-0E0236B13C1BQ37130834-4EE96120-738A-4DA6-A820-9BAC8B98D5DEQ37150299-94BA1607-3B09-469B-975D-FFE42142FD01Q37229386-91E5A598-DD91-4D44-B504-D315C0CC96B7Q37259642-A8264668-C235-4DF0-93CB-4A75525FB5DCQ37282817-CD9B09B1-5F17-4372-9311-D7A2467BB1A7Q37403499-822124C6-1B73-4F43-9657-3161C12D8A9D
P2860
Mechanisms of stimulation of the immune response by aluminum adjuvants.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@ast
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@en
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@nl
type
label
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@ast
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@en
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@nl
prefLabel
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@ast
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@en
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@nl
P1433
P1476
Mechanisms of stimulation of the immune response by aluminum adjuvants.
@en
P2093
Harm HogenEsch
P356
10.1016/S0264-410X(02)00169-X
P407
P478
20 Suppl 3
P577
2002-05-01T00:00:00Z